Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity

Michael R. Taylor; Kyle L. Flannigan; Hannah Rahim; Amina Mohamud; Ian A. Lewis; Simon A. Hirota; Steven C. Greenway

doi:10.1126/sciadv.aax2358

Research ArticleMICROBIOLOGY

Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity

View ORCID ProfileMichael R. Taylor¹,²,³,
Kyle L. Flannigan⁴,⁵,
View ORCID ProfileHannah Rahim¹,²,³,
View ORCID ProfileAmina Mohamud¹,²,³,
View ORCID ProfileIan A. Lewis⁶,
View ORCID ProfileSimon A. Hirota⁴,⁵,⁷ and
View ORCID ProfileSteven C. Greenway ¹,²,³,⁸,*

¹Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
²Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
³Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁴Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁵Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁶Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
⁷Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁸Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

↵*Corresponding author. Email: scgreenw{at}ucalgary.ca

See allHide authors and affiliations

Science Advances 07 Aug 2019:
Vol. 5, no. 8, eaax2358
DOI: 10.1126/sciadv.aax2358

Michael R. Taylor

1Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

2Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

3Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michael R. Taylor

Kyle L. Flannigan

4Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

5Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hannah Rahim

1Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

2Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

3Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hannah Rahim

Amina Mohamud

1Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

2Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

3Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Amina Mohamud

Ian A. Lewis

6Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ian A. Lewis

Simon A. Hirota

4Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

5Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

7Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Simon A. Hirota

Steven C. Greenway

1Departments of Pediatrics and Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

2Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

3Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

8Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Steven C. Greenway
For correspondence: scgreenw@ucalgary.ca

Article
Figures & Data
Info & Metrics
eLetters
PDF

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all . Please read our guidelines before submitting your own eLetter.

Submit a Response to This Article

Compose eLetter

Title

Contents

More information about text formats

Plain text

Plain text
No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First name and middle name First or given name, e.g. 'Peter'. Last Name Your last, or family, name, e.g. 'MacMoody'. Email Your email address, e.g. higgs-boson@gmail.com Role / Occupation Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests?

Yes

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

No eLetters have been published for this article.

View Full Text

Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity

Plain text

Vertical Tabs

Science Advances

Article Tools